![]() |
市場調查報告書
商品編碼
2035298
CBD注入型個人護理市場預測至2034年-按產品類型、成分、應用、通路、最終用戶和地區分類的全球分析CBD-Infused Personal Care Market Forecasts to 2034 - Global Analysis By Product Type, Source, Application, Distribution Channel, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球 CBD 注入個人護理市場將達到 48 億美元,並在預測期內以 5.9% 的複合年成長率成長,到 2034 年達到 76 億美元。
CBD 個人護理產品涵蓋護膚、護髮、身體保養、淋浴設備、彩妝、口腔護理和芳香療法產品。這些產品含有從大麻或工業大麻植物中提取的大麻二酚 (CBD),因其抗發炎、調節皮脂分泌、抗氧化和鎮痛功效而備受推崇。這些功效有助於改善痤瘡、濕疹、牛皮癬和老化等皮膚問題,同時也能促進頭皮健康、緩解緊張情緒並帶來感官上的愉悅。這些產品涵蓋所有外用產品類型,目標客戶是注重健康的美容和個人護理消費者。
CBD外用產品的有效性與消費者接受度
消費者對局部外用CBD產品在減輕皮膚發炎、治療痤瘡和抗衰老方面的功效信心日益增強,這得益於皮膚科醫生在社交媒體上發布的權威內容、獨立臨床研究的發表以及消費者積極的試用體驗。這促使高階CBD個人保健產品的市場接受度從早期使用者擴展到更廣泛的美容消費群體。對大麻素健康產品類型表現出高度認可的富裕千禧世代正在推動高階品牌的銷售成長。
各市場監管不一致
各國市場對CBD個人保健產品的法規結構分散且不一致,導致CBD濃度限制、標籤要求和分銷管道限制各不相同,從而增加了營運複雜性。這不僅提高了合規成本,也限制了CBD個人護理公司的國際品牌擴張。這種情況對歐盟打入市場策略的影響尤其顯著,因為歐盟各成員國對食品和化妝品新成分監管框架的適用情況不盡相同。
高階奢華CBD護膚的定位
高階護膚品牌拓展CBD產品線,帶來了豐厚的商機。這是因為高階美妝產品的消費者願意為知名品牌推出的奢華高濃度CBD配方產品支付更高的價格。科顏氏、雅詩蘭黛和歐萊雅旗下的高階品牌,憑藉其與奢侈品零售通路的穩固關係和品牌資產,實現了卓越的CBD產品銷售業績。這些優勢是獨立CBD品牌僅憑配方品質無法複製的。
CBD供應鏈中的品質差異
大麻萃取CBD原料供應鏈中的品質差異包括大麻素濃度準確性的波動、農藥殘留風險以及與THC污染相關的合規性挑戰。這些因素對依賴不同合約原料供應商的CBD個人護理品牌構成產品安全和監管合規風險,因為這些供應商的品管體係可能無法充分管理高級產品配方所需的大麻素含量,也無法滿足國際法規的要求。
新冠疫情期間,人們對健康領域的投資激增,壓力相關的皮膚問題也日益普遍,這顯著推動了CBD個人護理產品的普及。疫情加劇了皮膚敏感,更多消費者尋求具有消炎舒緩功效的外用產品。隨著主要市場疫情後監管的逐步恢復正常,以及消費者對健康投資的持續成長,CBD個人護理產品的市場准入和接受度不斷提高,逐漸克服了傳統大麻相關污名。
在預測期內,化妝品和彩妝領域預計將佔據最大的市場佔有率。
在預測期內,化妝品和彩妝領域預計將佔據最大的市場佔有率。這主要歸功於消費者對添加CBD成分的粉底、唇部護理產品和膚色修正產品的強勁需求。這些產品只需一次塗抹即可兼具彩妝的遮瑕效果和抗發炎功效,因此深受希望將CBD益處融入日常美容程序的消費者青睞,促使他們頻繁購買。高階CBD彩妝產品的售價遠高於傳統化妝品,這得益於其雙重功效。
預計在預測期內,大麻衍生的 CBD 細分市場將呈現最高的複合年成長率。
在預測期內,大麻提取CBD細分市場預計將呈現最高的成長率。這主要歸因於以下幾個因素:隨著國際農業市場對大麻種植的監管核准減少,大麻CBD的原料成本下降;消費者越來越傾向於選擇大麻提取CBD而非大麻提取CBD,因為大麻提取CBD的監管較少,品牌形像也更健康;以及對大麻提取技術的重大投資,旨在獲得適用於高階個人護理產品的高純度CBD。
在預測期內,北美預計將佔據最大的市場佔有率。這主要是因為美國和加拿大擁有全球最商業性的CBD個人護理市場,擁有完善的大麻法律規範,Charlotte's Web和CV Sciences等主要CBD美容品牌以及領先化妝品製造商的CBD產品線在國內創造了可觀的收入,而且通過Sephora、Ulta等零售商和天然美容管道構建的強大的天然美容管道構建的分銷產品的零售體係也為CBD產品的分銷提供了支持。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要歸功於澳洲、日本和韓國逐步完善大麻衍生CBD個人保健產品的法規結構,這將使國際CBD美容品牌能夠進入市場;這些市場中快速成長的健康美容消費群體對植物來源活性成分創新產品的強烈接受度;以及澳大利亞國內CBD原料供應鏈的擴張,推動了該地區生產經濟的改善。
According to Stratistics MRC, the Global CBD-Infused Personal Care Market is accounted for $4.8 billion in 2026 and is expected to reach $7.6 billion by 2034 growing at a CAGR of 5.9% during the forecast period. CBD-infused personal care refers to skincare, haircare, body care, bath and shower, cosmetics, oral care, and aromatherapy products formulated with cannabidiol extracted from hemp or cannabis plants, valued for its anti-inflammatory, sebum-regulating, antioxidant, and analgesic properties that address skin conditions including acne, eczema, psoriasis, and aging while providing scalp health, body tension relief, and sensory wellness benefits across topical application product categories targeting health-conscious beauty and personal care consumers.
CBD Topical Efficacy Consumer Adoption
Growing consumer confidence in topical CBD efficacy for skin inflammation reduction, acne management, and anti-aging benefit delivery through credible social media dermatologist content, independent clinical study publication, and positive consumer trial experience is driving premium CBD personal care product adoption beyond early adopter demographics into mainstream beauty consumers. Affluent millennial demographics demonstrating strong openness to cannabinoid wellness product categories are sustaining premium brand revenue growth.
Regulatory Inconsistency Across Markets
Fragmented and inconsistent CBD personal care product regulatory frameworks across national markets creating different permissible CBD concentration limits, labeling requirements, and distribution channel restrictions create operational complexity that increases compliance costs and limits international brand expansion for CBD personal care companies, particularly affecting market entry strategies in the European Union where novel food and cosmetic ingredient frameworks apply differently across member state jurisdictions.
Premium Luxury CBD Skincare Positioning
Luxury skincare brand CBD line extension development represents a premium revenue opportunity as prestige beauty consumers demonstrate strong willingness to pay substantial premiums for high-CBD-concentration luxury formulations from established brand houses, with Kiehl's, Estee Lauder, and L'Oreal premium subsidiaries generating superior CBD product revenue through established luxury retail relationships and brand equity that indie CBD brands cannot replicate through formulation quality alone.
CBD Supply Chain Quality Inconsistency
Hemp-derived CBD ingredient supply chain quality inconsistency including variable cannabinoid concentration accuracy, pesticide residue risk, and THC contamination compliance challenges create product safety and regulatory compliance risks for CBD personal care brands dependent on diverse contract ingredient suppliers whose quality management systems may inadequately control cannabinoid profile specifications required for consistent premium product formulation and international regulatory compliance.
COVID-19 wellness investment surge and stress-related skin condition prevalence during pandemic periods generated significant CBD personal care category trial as consumers sought anti-inflammatory and calming topical formulations for pandemic-exacerbated skin sensitivity conditions. Post-pandemic regulatory normalization progress in key markets and sustained consumer wellness investment momentum continue expanding CBD personal care market access and consumer acceptance beyond legacy cannabis-associated stigma barriers.
The cosmetics & makeup segment is expected to be the largest during the forecast period
The cosmetics & makeup segment is expected to account for the largest market share during the forecast period, due to strong consumer demand for CBD-infused foundation, lip care, and complexion products that combine color cosmetic coverage with anti-inflammatory skin benefit delivery in a single application occasion, generating high-frequency purchase behavior among makeup consumers incorporating CBD benefit positioning into daily beauty routines. Premium CBD makeup formulations command significant price premiums over conventional cosmetic alternatives justified by dual-function benefit delivery.
The hemp-derived CBD segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hemp-derived CBD segment is predicted to witness the highest growth rate, driven by expanding hemp cultivation regulatory approval across international agricultural markets reducing hemp CBD raw material costs, growing consumer preference for hemp-derived over marijuana-derived CBD sources due to lower regulatory restriction burden and cleaner brand positioning, and substantial investment in hemp extraction technology improvement delivering higher-purity CBD ingredient grades suitable for premium personal care applications.
During the forecast period, the North America region is expected to hold the largest market share, due to the United States and Canada hosting the world's most commercially developed CBD personal care markets with established hemp regulation frameworks, leading CBD beauty brands including Charlotte's Web, CV Sciences, and major beauty house CBD lines generating substantial domestic revenue, and strong natural beauty retail infrastructure through Sephora, Ulta, and specialty natural channels supporting CBD product distribution.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to Australia, Japan, and South Korea progressively clarifying hemp-derived CBD personal care regulatory frameworks enabling market entry for international CBD beauty brands, rapidly growing wellness beauty consumer segments in these markets demonstrating strong receptiveness to botanical active ingredient innovation, and expanding domestic CBD ingredient supply chain development in Australia driving regional production economics improvement.
Key players in the market
Some of the key players in CBD-Infused Personal Care Market include Canopy Growth Corporation, Aurora Cannabis Inc., CV Sciences Inc., Charlotte's Web Holdings Inc., Elixinol Global Limited, Endoca BV, The Estee Lauder Companies Inc., L'Oreal S.A., Unilever PLC, Procter & Gamble Co., Johnson & Johnson, Colgate-Palmolive Company, Kiehl's LLC, Sephora (LVMH), Cronos Group Inc., Tilray Brands Inc., and Medterra CBD.
In March 2026, Charlotte's Web Holdings Inc. launched a new premium CBD-infused facial serum collection with clinically substantiated anti-inflammatory and skin barrier support evidence targeting natural beauty retail expansion across US and Canadian pharmacy chains.
In February 2026, Kiehl's LLC expanded its hemp-derived CBD skincare range with new body care formulations featuring broad-spectrum hemp extract targeting muscle tension relief and skin conditioning for active lifestyle consumer segments.
In December 2025, CV Sciences Inc. secured a major beauty retailer partnership placing its Plus CBD Oil personal care products across 1,500 additional retail doors through a national pharmacy chain health and beauty category expansion program.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.